Drug Tariffs Will Affect Millions Of Americans And Could Complicate Care
Many drugs use active ingredients that are manufactured outside the U.S., among them the anticoagulant heparin, which 12 million patients use each year. Meanwhile, AstraZeneca's Chairman Michel Demaré says pharmaceutical tariffs will hurt patients.